MJFF Targets to Therapies: Mitochondrial Target Validation
Supports mitochondrial target validation in Parkinson's research to build stronger therapy-ready evidence.
The Michael J. Fox Foundation Targets to Therapies: Mitochondrial Target Validation program is a two-stage competitive grant designed to build a robust evidence base for mitochondrial targets with high potential relevance to Parkinson's disease. MJFF, which has committed over $2 billion to PD research and is one of the world's largest private funders in the field, structured this program around fu…
Funds target modulation, human relevance evidence, mechanism clarification, biomarker identification, and safety characterization for mitochondrial targets with high potential relevance to Parkinson's disease.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Sign up free to see where teams trip up